Breaking News Instant updates and real-time market news.

FB

Facebook

$186.85

2.52 (1.37%)

, PCLN

Ticker changed to BKNG

$1,823.54

16.29 (0.90%)

06:02
01/08/18
01/08
06:02
01/08/18
06:02

JPMorgan calls Facebook best idea for 2018, ups target to $230

JPMorgan analyst Doug Anmuth calls Facebook (FB) his best idea for 2018 and raised his price target for the shares to $230 from $225. The social media giant closed Friday up $2.52 to $186.85. The analyst's favorite names for 2018 are Facebook, Priceline (PCLN) and Amazon (AMZN) among large-caps and Twitter (TWTR) and Yelp (YELP) among smid-caps. Facebook continues to show a "rare and impressive" combination of scale, growth and profitability, Anmuth tells investors in a research note. The analyst expects continued strong engagement and highlights the "rapid growth" at Instagram, which he believes could double over time and ultimately approach core Facebook platform scale. He keeps an Overweight rating on the shares.

FB

Facebook

$186.85

2.52 (1.37%)

PCLN

Ticker changed to BKNG

$1,823.54

16.29 (0.90%)

AMZN

Amazon.com

$1,229.14

19.55 (1.62%)

TWTR

Twitter

$24.32

0.33 (1.38%)

YELP

Yelp

$43.17

0.35 (0.82%)

  • 08

    Jan

  • 09

    Jan

  • 11

    Jan

  • 23

    Jan

  • 31

    Jan

  • 07

    Feb

  • 18

    Mar

FB Facebook
$186.85

2.52 (1.37%)

12/20/17
JEFF
12/20/17
NO CHANGE
Target $225
JEFF
Buy
Facebook 'Watch' tab could add $12B to sales in 2022, says Jefferies
Jefferies analyst Brent Thill thinks Facebook's "Watch" tab will extend its reach into user's video consumption. The "Watch" tab should drive video engagement and provide additional network effects and sharing, Thill tells investors in a research note. The analyst likes Facebook's data-driven approach to content creation and partner revenue share agreements as it manages content investment. He believes "Watch" could drive an incremental $1B of revenue in 2019 and $12B in 2022. The analyst keeps a Buy rating on Facebook with a $225 price target.
01/02/18
RHCO
01/02/18
NO CHANGE
Target $7
RHCO
Hold
Pandora 2018 EBITDA consensus is too high, says SunTrust
SunTrust analyst Matthew Thornton lowered his price target on Pandora (P) to $7 from $8 and kept his Hold rating, saying that while he is positive on the company's initiatives to boost User Hours and Subscriptions, they will take time and investment to materialize. Thornton says the consensus EBITDA view of -$42M is too high, given the expected rise in costs. The analyst also points to "intense" competition in streaming music as well as potential entry in the space at Facebook (FB), based on its music hires and content licensing.
12/18/17
JPMS
12/18/17
NO CHANGE
Target $1375
JPMS
Overweight
JPMorgan calls Facebook, Priceline and Amazon top 2018 Internet picks
JPMorgan analyst Doug Anmuth raised his price target for Amazon.com (AMZN) to $1,375 from $1,220, for Priceline (PCLN) to $2,050 from $1,950 and for Yelp (YELP) to $55 from $52 in conjunction with his 2018 outlook for the Internet sector. The analyst this morning also upgraded Twitter (TWTR) to Overweight from Neutral and raised his price target for the shares to $27 from $20. Anmuth's best Internet ideas for 2018 are Facebook (FB), Priceline and Amazon for large-caps and Twitter and Yelp for smid-caps.
01/05/18
SBSH
01/05/18
NO CHANGE
Target $1400
SBSH
Buy
Citi names Amazon top Internet pick for 2018, ups target to $1,400
Citi analyst Mark May remains bullish on the consumer Internet sector, especially over the near term. The analyst believes a "positive, tax reform fueled, business climate" should benefit the end-markets of the companies in the space. After outperformance in 2017, however, he recommends being more selective in 2018. Amazon.com (AMZN) moves up a spot to become his top-ranked pick for 2018. May sees the combination of greater than 30% sales growth, margin expansion and the current valuation as a "compelling mix." He raised his price target for Amazon shares to $1,400 from $1,250. May's most- to least-favored stocks under coverage, in order, are: Amazon, Expedia (EXPE), Facebook (FB), Priceline (PCLN), Alphabet (GOOGL), eBay (EBAY), Yelp (YELP), Twitter (TWTR), TripAdvisor (TRIP), Netflix (NFLX), GrubHub (GRUB), GoDaddy (GDDY), Despegar.com (DESP), trivago (TRVG), LendingClub (LC), Wayfair (W), Snap (SNAP), Zillow (ZG), Blue Apron (APRN) and Roku (ROKU), which he downgraded this morning to Sell.
PCLN Ticker changed to BKNG
$1,823.54

16.29 (0.90%)

01/04/18
DBAB
01/04/18
NO CHANGE
Target $10
DBAB
Buy
trivago jumps with Deutsche seeing signs of Booking.com 'inching back'
Shares of trivago (TRVG) are moving higher after Deutsche Bank analyst Lloyd Walmsley reported that Priceline's (PLCN) Booking.com advertisements are back on the trivago site in Germany. Walmsley, in a research note last night to investors, said he sees signs that Booking.com is "inching back to trivago, on the margin." The key advertiser returned to German points of sales on trivago.de after several weeks of essentially being absent from the site, the analyst wrote. Since late December, Walmsley has observed Booking.com ads back on the site in Germany as it continues an elevated level of testing with its ad spend on trivago. He sees the return to more normalized bidding levels in Germany as a positive and continues to view the risk/reward on trivago shares as "compelling." The analyst reiterated a Buy rating on the stock with a $10 price target. trivago in early trading is up 8%, or 57c, to $7.88.
12/22/17
MSCO
12/22/17
NO CHANGE
MSCO
Morgan Stanley calls GrubHub 'clearest winner' in U.S. Internet from tax act
Following the passage of the Tax Cuts and Jobs Act, Morgan Stanley analyst Brian Nowak reviewed the potential impact to the U.S. Internet stocks he covers. He believes that GrubHub (GRUB) is the "clearest winner" in the group from the lowering of the Federal statutory tax rate to 21% from 35% and identifies Priceline (PCLN) and eBay (EBAY) as having the largest stores of overseas cash and the greatest ability to return capital to shareholders with that cash. Nowak has Overweight ratings on GrubHub and Priceline and an Underweight rating on eBay.
01/05/18
SBSH
01/05/18
DOWNGRADE
Target $7.4
SBSH
Neutral
Citi sees estimate risk, downgrades trivago to Neutral
Citi analyst Mark May downgraded trivago (TRVG) to Neutral from Buy and cut his price target for the shares to $7.40 from $9.50. Management comments at the December 7 investor day suggest Priceline (PCLN) spend may not have improved as much as hoped, May tells investors in a research note. He believes consensus estimates may still be at risk and that trivago's long-term growth and profitability remains uncertain.
AMZN Amazon.com
$1,229.14

19.55 (1.62%)

01/04/18
MONN
01/04/18
NO CHANGE
MONN
Ulta rises after Monness Crespi calls company a better Amazon 'target'
Pre-market strength in shares of Ulta Beauty (ULTA) is being attributed to a suggestion made by an analyst at Monness Crespi that the company could be a better M&A fit for Amazon (AMZN) than Target (TGT). AMAZON ALTERNATIVES: In a note to investors this morning, Monness, Crespi, Hardt analyst James Cakmak noted the speculation that has swirled since Amazon's deal to buy Whole Foods about what categories and kinds of companies the e-commerce giant might acquire. He also noted that Target (TGT) most recently "has been floated as a prospect," but he doesn't see how such a deal would "change the game" in terms of pricing and selection for Amazon. Beauty is a category important for Amazon, and Ulta Beauty could be an M&A fit, Cakmak said. Lyft would also makes sense, as would a purchase of Costco (COST), even though that hypothetical deal "is highly unlikely," Cakmak also told investors. WHAT'S NOTABLE: Cakmak's note appears to be in response to Loup Venture's Gene Munster having said yesterday that Amazon may be eyeing Target as its next major retail acquisition. PRICE ACTION: In pre-market trading, Ulta is up $4.78, or 2%, to $249.90 per share.
01/05/18
SBSH
01/05/18
NO CHANGE
Target $80
SBSH
Neutral
Citi ups Wayfair target to $80 after adding in takeover premium
Citi analyst Mark May raised his price target for Wayfair (W) to $80 to reflect the benefits from tax reform as well as the addition of an M&A premium. Recent conversations with investors indicate that more of them believe Wayfair could be an acquisition target, either by Amazon (AMZN) or by a company looking to better compete with Amazon, May tells investors in a research note. His new price target assumes a 50% probability of an acquisition at a 35% premium. The analyst keeps a Neutral rating on the shares.
01/05/18
SBSH
01/05/18
DOWNGRADE
Target $28
SBSH
Sell
Roku downgraded to Sell from Neutral at Citi
Citi analyst Mark May downgraded Roku (ROKU) to Sell while raising his price target for the shares to $28 from $27. The shares closed yesterday down 8% to $51.24 after Morgan Stanley downgraded the name to Underweight. The stock is up 266% from its initial public offering price of $14 just three months ago, May tells investors in a research note. The analyst is positive on the long-term growth of the over-the-top video market and on Roku's growth outlook, but believes the current valuation is more than reflecting that outlook. Potential catalysts for a share selloff include the lockup expiration in March, earnings results that don't rise to bullish expectations, and increased competition from the likes of Google (GOOG), Amazon (AMZN) or Apple (AAPL), May contends.
TWTR Twitter
$24.32

0.33 (1.38%)

12/18/17
12/18/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Twitter (TWTR) upgraded to Overweight from Neutral at JPMorgan with analyst Doug Anmuth saying both the company's investment story and financial results will strengthen in 2018 as Twitter builds on its "differentiated value proposition" for users and returns to revenue growth. 2. Akamai (AKAM) upgraded to Outperform from Neutral at Credit Suisse with analyst Brad Zelnick citing the 13D filing by activist investor Elliott Management. 3. Costco (COST) upgraded to Outperform from Market Perform at BMO Capital with analyst Kelly Bania saying the acceleration in the company's online business is at an early stage, which should support its outlook for strong comps and higher valuation. 4. General Mills (GIS) upgraded to Outperform from Market Perform at Wells Fargo with analyst John Baumgartner saying U.S. retail takeaway is improving faster than he expected, which suggests potential upside to the company's guidance during fiscal 2018. 5. Discover (DFS) and Synchrony (SYF) were upgraded to Buy from Neutral at BofA Merrill Lynch. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/18/17
12/18/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Twitter (TWTR) initiated with a Buy at Summit Redstone. 2. Insteel (IIIN) initiated with a Buy at Sidoti. 3. Tiffany (TIF) initiated with a Neutral at JPMorgan. 4. Delphi Technologies (DLPH) initiated with a Buy at Jefferies. 5. Domino's Pizza (DPZ) initiated with a Buy at Deutsche Bank, while Papa John's and Wingstop (WING) were initiated with a Hold. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
12/20/17
ARGS
12/20/17
NO CHANGE
Target $30
ARGS
Buy
Twitter price target raised to $30 from $25 at Argus
Argus analyst Jim Kelleher raised his price target price on Twitter to $30 from $25, stating that he believes the shares have further to go despite the stock's over 25% run-up since his upgrade in November. Twitter is restoring growth while seeking to improve, but not stifle, the user experience and Kelleher thinks its continued work on refining and clarifying its policy on toxic content can help restore the company's early mission of serving as a platform for public self-expression, he tells investors. Kelleher keeps a Buy rating on Twitter shares.
YELP Yelp
$43.17

0.35 (0.82%)

12/06/17
PIPR
12/06/17
DOWNGRADE
Target $37
PIPR
Underweight
Yelp downgraded to Underweight from Neutral at Piper Jaffray
Piper Jaffray analyst Sam Kemp downgraded Yelp (YELP) to Underweight from Neutral and lowered his price target for the shares to $37 from $38. The stock closed the trading day down $1.02 to $41.88. Given the "messiness" of removing Eat24, investors missed that Yelp lowered organic Q4 guidance by 2%, Kemp tells investors in a research note. He believes the company may guide down 2018 revenue when reporting Q4 results. Further, the analyst thinks Yelp's believe traffic will become more difficult as Facebook (FB) and Google (GOOG, GOOGL) aggressively route traffic to their own offerings. In addition, Kemp does not view Yelp as an acquisition candidate.
12/07/17
12/07/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Yelp (YELP) downgraded to Underweight from Neutral at Piper Jaffray with analyst Sam Kemp saying given the "messiness" of removing Eat24, investors missed that Yelp lowered organic fourth quarter guidance by 2%. 2. Toll Brothers (TOL) downgraded to Outperform from Strong Buy at Raymond James with analyst Buck Horne saying fiscal 2018 gross margins are more cautious than expected due to New York City headwinds ahead of an upcoming supply wave. 3. Priceline (PCLN) and Expedia (EXPE) were downgraded to Neutral from Buy at MKM Partners. 4. Ctrip.com (CTRP) downgraded to Neutral from Overweight at JPMorgan with analyst Alex Yao saying the introduced an opt-in option in early October by removing part of the default purchase setting of bundled products. 5. Allergan (AGN) downgraded to Hold from Buy at Argus analyst David Toung saying the company's Botox may face increasing competition from a botulinum toxin-based product being developed by Revance Therapeutics (RVNC) by 2020. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

BUD

AB InBev

05:55
05/22/18
05/22
05:55
05/22/18
05:55
Upgrade
AB InBev rating change  »

AB InBev upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MMM

3M

$201.75

2.8 (1.41%)

, BAYRY

Bayer

$0.00

(0.00%)

05:55
05/22/18
05/22
05:55
05/22/18
05:55
Conference/Events
American Thoracic Society to hold a conference »

ATS 2018 will be held in…

MMM

3M

$201.75

2.8 (1.41%)

BAYRY

Bayer

$0.00

(0.00%)

BDX

Becton Dickinson

$228.74

3.73 (1.66%)

BIIB

Biogen

$277.69

-2.66 (-0.95%)

STEM

Ticker changed to MBOT

$0.00

(0.00%)

TEVA

Teva

$21.09

-0.14 (-0.66%)

UTHR

United Therapeutics

$104.12

-2.2 (-2.07%)

VCYT

Veracyte

$6.45

(0.00%)

VRTX

Vertex

$156.15

-1.09 (-0.69%)

NBRV

Nabriva Therapeutics

$4.54

-0.89 (-16.39%)

GILD

Gilead

$67.63

-0.38 (-0.56%)

GSK

GlaxoSmithKline

$40.05

0.005 (0.01%)

HRC

Hill-Rom

$90.70

0.12 (0.13%)

INNV

Innovus Pharmaceuticals

$0.00

(0.00%)

DNA

Bought by RHHBY

$0.00

(0.00%)

CELG

Celgene

$74.69

-3.7 (-4.72%)

JAZZ

Jazz Pharmaceuticals

$166.01

-1.59 (-0.95%)

ISRG

Intuitive Surgical

$463.18

4.3 (0.94%)

INSM

Insmed

$26.34

-2.16 (-7.58%)

REGN

Regeneron

$296.58

-5.29 (-1.75%)

OCX

OncoCyte

$2.50

-0.05 (-1.96%)

FGEN

FibroGen

$52.55

1.45 (2.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 24

    May

  • 30

    May

  • 30

    May

  • 31

    May

  • 03

    Jun

  • 05

    Jun

  • 05

    Jun

  • 12

    Jun

  • 13

    Jun

  • 13

    Jun

  • 14

    Jun

  • 16

    Jun

  • 25

    Jun

  • 26

    Jun

  • 11

    Aug

  • 20

    Oct

  • 20

    Dec

CCJ

Cameco

$11.38

0.015 (0.13%)

05:54
05/22/18
05/22
05:54
05/22/18
05:54
Downgrade
Cameco rating change  »

Cameco downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TER

Teradyne

$38.17

0.77 (2.06%)

05:54
05/22/18
05/22
05:54
05/22/18
05:54
Conference/Events
Teradyne management to meet with Craig Hallum »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 30

    May

RTN

Raytheon

$213.95

2.88 (1.36%)

05:54
05/22/18
05/22
05:54
05/22/18
05:54
Downgrade
Raytheon rating change  »

Raytheon downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYRS

Syros Pharmaceuticals

$11.96

-0.41 (-3.31%)

05:54
05/22/18
05/22
05:54
05/22/18
05:54
Conference/Events
Syros Pharmaceuticals management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

SPSC

SPS Commerce

$71.88

0.11 (0.15%)

05:53
05/22/18
05/22
05:53
05/22/18
05:53
Conference/Events
SPS Commerce management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

  • 29

    May

  • 12

    Jun

RDCM

Radcom

$19.65

0.25 (1.29%)

05:52
05/22/18
05/22
05:52
05/22/18
05:52
Conference/Events
Radcom management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

  • 24

    May

  • 29

    May

INFO

IHS Markit

$51.60

0.13 (0.25%)

05:52
05/22/18
05/22
05:52
05/22/18
05:52
Upgrade
IHS Markit rating change  »

IHS Markit upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FITB

Fifth Third

$30.89

-2.66 (-7.93%)

05:51
05/22/18
05/22
05:51
05/22/18
05:51
Upgrade
Fifth Third rating change  »

Fifth Third upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QTM

Quantum

$3.62

-0.06 (-1.63%)

05:51
05/22/18
05/22
05:51
05/22/18
05:51
Conference/Events
Quantum management to meet with Lake Street »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 29

    May

FITB

Fifth Third

$30.89

-2.66 (-7.93%)

05:51
05/22/18
05/22
05:51
05/22/18
05:51
Upgrade
Fifth Third rating change  »

Fifth Third upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OTEX

OpenText

$34.10

0.1 (0.29%)

05:51
05/22/18
05/22
05:51
05/22/18
05:51
Conference/Events
OpenText management to meet with Benchmark »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

NVEE

NV5 Global

$60.60

0.6 (1.00%)

05:50
05/22/18
05/22
05:50
05/22/18
05:50
Conference/Events
NV5 Global management to meet with Lake Street »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

  • 09

    Jun

  • 12

    Jun

  • 13

    Jun

M

Macy's

$34.60

0.63 (1.85%)

05:49
05/22/18
05/22
05:49
05/22/18
05:49
Upgrade
Macy's rating change  »

Macy's upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCR

NCR Corp.

$31.30

0.11 (0.35%)

05:49
05/22/18
05/22
05:49
05/22/18
05:49
Conference/Events
NCR Corp. management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

ONCE

Spark Therapeutics

$73.03

-3.69 (-4.81%)

, PFE

Pfizer

$35.79

0.15 (0.42%)

05:44
05/22/18
05/22
05:44
05/22/18
05:44
Hot Stocks
Spark Therapeutics, Pfizer announce data SPK-9001 ongoing Phase 1/2 trial »

Spark Therapeutics (ONCE)…

ONCE

Spark Therapeutics

$73.03

-3.69 (-4.81%)

PFE

Pfizer

$35.79

0.15 (0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 10

    Sep

FMC

FMC Corporation

$91.30

-0.22 (-0.24%)

05:41
05/22/18
05/22
05:41
05/22/18
05:41
Hot Stocks
FMC Corporation awarded contract for two fertilizer plants in India »

TechnipFMC, in consortium…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

S

Sprint

$5.17

0.05 (0.98%)

05:40
05/22/18
05/22
05:40
05/22/18
05:40
Hot Stocks
Sprint partners with Scopeworker on multi-billion dollar 5G depoloyment »

Scopeworker announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GSHD

Goosehead Insurance

$16.19

0.12 (0.75%)

05:39
05/22/18
05/22
05:39
05/22/18
05:39
Initiation
Goosehead Insurance initiated  »

Goosehead Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMAR

Smartsheet

$20.00

0.14 (0.70%)

05:38
05/22/18
05/22
05:38
05/22/18
05:38
Initiation
Smartsheet initiated  »

Smartsheet initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

VLRS

Volaris

$5.42

-0.05 (-0.91%)

05:19
05/22/18
05/22
05:19
05/22/18
05:19
Recommendations
Volaris analyst commentary  »

Volaris price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAX

Baxter

$72.08

1.4603 (2.07%)

05:16
05/22/18
05/22
05:16
05/22/18
05:16
Recommendations
Baxter analyst commentary  »

Baxter buybacks should…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DOCU

DocuSign

$43.06

-1.73 (-3.86%)

05:08
05/22/18
05/22
05:08
05/22/18
05:08
Initiation
DocuSign initiated  »

DocuSign initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jun

AROC

Archrock

$12.30

0.35 (2.93%)

05:07
05/22/18
05/22
05:07
05/22/18
05:07
Recommendations
Archrock analyst commentary  »

Archrock added to Alpha…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.